Hospira issues nationwide recall for opioid overdose reversal drug

This article was originally published here

Pfizer’s Hospira unit this week voluntarily recalled two lots of a drug used to reverse the course of an opioid overdose.

The company’s naxolone injection, sold in its Carpuject single-use cartridge syringe, was recalled due to the potential presence of embedded and loose particulate matter in the plunger.

Get the full story at our sister site, Drug Delivery Business News.

The post Hospira issues nationwide recall for opioid overdose reversal drug appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply